Member Info for TWatcher

"I wonder if, following their experience with the AbC19 test, ODX et al are holding off signing another DHSC contract with that provision in?"

given that they got exactly bugger all out of the last one, I think its certain that this time around any exclusivity will be based on a minimum order and no get out of jail free card related to compliance or independant testing results.

"we will be selling all we can make."

A phrase that was used repeatedly for 6 months by those that thought UK gov was going to roll out antibody testing hand-in-hand with vaccine. Hyperbole that was again repeated by many, that has suddenly disappeared. Even CK stated that he believed that mass vaccination meant mass antibody testing, I know because I asked the question.

Suddenly mass antibody testing along with mass vaccination just disappeared on this board. Its an important lesson about expectation and reality in relation to ODX and LFT testing, that many conveniently ignore.

I have never said there will not be orders. I have said there are no orders, which conflicts all those DOZENS of posts that have said there are orders and simply are not announced because of NDA. That is factually incorrect and has been repeated ad naseum by many on here without challenge by most.

There are no orders.

they were caught in the negative press last week, but not mentioned in the positive press.

ABDX can possibly benefit from antigen testing, as their business model includes them being an outsourced manufacturer, but they have not announced a formal tie-up to make someone elses test as I understand it.

Give the furore around the government's ordering from the RTC, the last thing gov is going to do is order a product that does not exist, and has not passed formal gov testing at porton down.

There will be no immediate RNS as there simply can NOT be an order. Whether there is some understanding is a different matter, as is the ability of the press's source to have accurate information and understand it correctly.

"They must be awfully close though, for the 'leaked' FT article not to be disputed."
As a listed company, constantly commenting on press articles is problematic as people then start to make judgements when a company does not comment on a press article.

Surescreen is not a listed company, they are under much looser rules as to what they can say. Surescreen also have a confirmed 2M unit order, I think this is separate from the newsflow over the weekend.

ODX is a listed company and therefore required to followed guidelines about making statements that might be price sensitive. As has been repeated by ODX today, the company is obligated to announce via RNS when they receive significant orders. As ODX has not released an order related RNS since OCT, you can be certain that they have no orders at this time that are price significant for ANY LFT products. This is not surprising in the case of LFT antigen, as they do not have an LFT antigen product that can be ordered, it is still being worked on. It is thought that the RTC antibody test is being held back for sales due to gov being sole possible buyer until 15th of Feb, which is a reasonable narrative. However the visitect antibody test has been available for unrestricted sales for several months now, and no order related RNS has been issued, it therefore has not had any price significant orders.

There will likely be a chorus of people who will tell you I am a deramper, but note that whilst doing so, none will argue that the company have released order related RNSs, and the company have repeatedly stated that orders are RNSed. The statement that there are no price sensitive orders is a fact, which is why it will not be argued.

"Maybe xmas holidays has made it take a little longer than had it had started in say November"
They weren't aware christmas was coming when they set the timescale ?

the contract won by deloitte is for
"Provision of Management Consultancy Services"

"our team will contact you to confirm final costs, payment options and shipping details."

Suggest shipping details will be "we'll ship on the 15 of Feb"

which part of "that indicates this this 1.1B study will not be usinf LFT antibody tests", did you take issue with ?

"recruitment of phlebotomists as Study Workers for the collection of venous blood samples"

Thats indicates that this 1.1B study will not be using LFT antibody tests.

I don't think that Abingdon misled in relation to the outcome of the original contract. They said the government would not be ordering any more under that contract. There is remaining doubt whether the contract is in place or has been cancelled. It would seem illogical for the gov to force a contract term to run out, from which there ZERO chance of them ordering more LFT, all that does is impede industry for no reason. I assume it's been cancelled, as anything else doesn't make sense.

The issue of MHRA approval is an awkward one. Technically, if Abingdon have already announced that the contract for which MHRA approval was important is no longer going to generate any more orders, and Abingdon does not see any further orders requiring MHRA approval for home use, then approval or rejection is no longer price sensitive information, and as such need not be announced.

The awkwardness comes from yjr company itself putting emphasis on it's importance by advising shareholders that MHRA has requested another short term field study, with a tone that suggested that approval would be granted. To then just suddenly go quiet on the status of the MHRA approval raises questions.

capacity will be used
we will sell all we can make.

What are these, some sciencetology derived mantras that are parrotted out for self-assurance purposes ?

Another date in the future, another big prize.

MHRA approval was the big prize....just wait for that and see the rocket

The tight association between RTC test and OX/AZ, and a "hand-in hand" rollout meant that the start of vaccination was the big prize

"Christmas present" was the big prize

Announcement of the first Gov contract was the big prize.

Sales of visitect antibody test was the big prize

I could not give a fiddles for DHSC embarassement. I am worried that the market doesn't like it
1) MHRA approval is not up in the air, depend on who you beleive.
2) Unclear whether the existing contract is cancelled or will naturally expire. for those wondering what the difference is, if it's cancelled, RTC can sell to non-DHSC immediately. If it's going to naturally expire, then unless DHSC gives permission, it needs to expire before non-DHSC sales can commence.

Regardless, RTC made big noises as to the kudos this test would have internationally, being sponsored by UK gov, and it's preferred customer. That Kudos has turned negative.

One wonders why Abington faired better than ODX when the knives were out, given Abingdon was getting 50% of the contract, whilst ODX was getting 25%.

Pommy1972

Was there anything in my last post that was factually incorrect ?

"Boris has flashed open the kimono"

I'm gonna need another drink

it's a clear and real fact that ODX has no price significant orders, as they have to be announced. Clearly they expect to have orders, given the sharp increase in workforce and capacity and their statements. The employement of PA consulting to facilitate domestic LFT volume of 2M LFT a day is also exteremely encouraging. But to take that and state as a fact that they have orders needs to be challenged, as its fake news...they do not have orders.

Unfortunately, the world we live in is increasingly comprised of people that prefer to be cocooned in their alternative facts world, and are prepared to only tune into channels that agree with their personal facts.

And what must be blindedly clear even to the most myopic, is that it is the fact that they do not have orders that is holding the SP back. As soon as they announce signficant orders the SP will respond.

Honestly get real...you really are absurd!

I am real, there are no orders of price significance, ODX RNS list is very real in this regard.